Janux Therapeutics
+$0.16 (+1.23%) As of 1:35 PM UTC today
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JANX and other ETFs, options, and stocks.
About JANX
Janux Therapeutics, Inc. operates preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in La Jolla, CA.
CEO
David Campbell
Employees
33
Headquarters
La Jolla, California
Founded
2017
JANX Key Statistics
Market cap
549.51M
Price-Earnings ratio
—
Dividend yield
—
Average volume
150.05K
High today
$13.20
Low today
$13.20
Open price
$13.20
Volume
130.00
52 Week high
$35.93
52 Week low
$9.39
JANX Earnings
-$0.62
-$0.41
-$0.21
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 9, After Hours